
Biosimilar products (Ep. 25)
Today’s show discussed biosimilar development from a clinical pharmacology perspective. I describe what biosimilar products are and the necessary comparisons to the reference product. I review require...
13 Maj 202416min

Choosing an absorption model (Ep. 24)
Today’s show discussed approaches for modeling absorption profiles. I discussed the rationale behind modeling absorption and then described some common models. These included first-order absorption, z...
22 Apr 202424min

What is Aplos NCA? (Ep. 23)
Today’s show was an overview of Aplos Analytics and the development story for Aplos NCA. Please consider participating in the Early Access Program. Use the link below to learn more about Aplos NCA. Li...
8 Apr 202429min

Big announcement and Hepatic impairment studies (Ep. 22)
Today’s show is about hepatic impairment clinical studies. I cover the rationale behind evaluating hepatic impairment, common study designs, and key factors in the analysis and interpretation of the s...
25 Mars 202418min

Project Optimus (Ep. 21)
Today’s episode was about Project Optimus, the FDA initiative to improve dose selection and optimization for oncology products. Julie Bullock was a guest on this episode and shared her expertise as a ...
11 Mars 202439min

Tackling TMDD Models (Ep. 20)
Today’s show is about TMDD or target-mediated drug disposition models. I review the scientific and physiologic basis for TMDD models, how to review data and determine if a TMDD model is needed. I revi...
26 Feb 202415min

Communication for scientists (Ep. 19)
Today’s episode is about communication for scientists. I believe that improvements in communication skills can have a greater impact on your career and work than technical skills. Michael Piperno, an ...
12 Feb 202446min

Cell Therapy and Clinical Pharmacology (Ep. 18)
Today’s episode is about cell therapies, including CAR T-cell theraphy for cancer. I give an overview of cell therapy and the challenges of clinical pharmacology in this new area of research. Links d...
22 Jan 202413min


















